***PRESS-RELEASE: Takeda Completes Sale of Xiidra

Home > Newsroom > Top Stories > ***PRESS-RELEASE: Takeda Completes Sale of Xiidra

***PRESS-RELEASE: Takeda Completes Sale of Xiidra

Osaka, Japan - July 1, BUSINESS WIRE - Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) ("Takeda") today announced the completion of its sale of its Xiidra

News and other data on this site are provided for information purposes only, and are not intended for republication or redistribution. Republication or redistribution of Interfax content, including by framing or similar means, is expressly prohibited without the prior written consent of Interfax.